Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20121
20141
20152
20173
20191
20201
20213
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed5
Terminated3
Active, not recruiting3
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK2
Eli Lilly and Company2
Abbott1
Auricula Biosciences Inc.1
Bristol-Myers Squibb1
Cambridge University Hospitals NHS Foundation Trust1
Centocor, Inc.1
Daiichi Sankyo1
Grey Wolf Therapeutics1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms20
Carcinoma, Non-Small-Cell Lung13
Head and Neck Neoplasms10
Colorectal Neoplasms8
Neoplasms7
Breast Neoplasms5
Colonic Neoplasms5
Thyroid Neoplasms5
Bronchial Neoplasms4
Carcinoma, Bronchogenic4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.